Publications
5530 Results
- Journal / Conference
- ASCO #C-455
- Year
- 1983
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7510
The SWOG large bowel adjuvant program. An update.
- Journal / Conference
- ASCO #C-443
- Year
- 1983
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7804
Adjuvant chemotherapy with 5-Fluorouracil, Adriamycin and Mitomycin (FAM) in gastric cancer - A SWOG study.
- Journal / Conference
- ASCO #C-478
- Year
- 1983
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7841
Southwest Oncology Group Phase II-III gastric cancer study: 5-Fluorouracil, Adriamycin, and Mitomycin-C + Vincristine (FAM vs V-FAM) compared to chlorozotocin (CZT), m-AMSA, and Dihydroxyanthracenedione (DHAD) with unimpressive differences.
- Journal / Conference
- ASCO #C-469
- Year
- 1983
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7940/45
Evaluation of 5-FU vs. a Phase II drug in metastatic adenocarcinoma of the large bowel: Southwest Oncology Group (SWOG) study 7940.
- Journal / Conference
- ASCO #C-496
- Year
- 1983
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7940/45
AZQ in the treatment of colon cancer - A Southwest Oncology Group study.
- Journal / Conference
- ASCO #C-510
- Year
- 1983
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8017
Phase II trial of 5FU, Adriamycin, Cyclophosphamide, and Streptozotocin (FAC-S) in metastatic carcinoid (for the Southwest Oncology Group).
- Journal / Conference
- Int J Rad Onc Bio Phys 9:1885-1890
- Year
- 1983
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7525
The Southwest Oncology Group experience. Adjuvant therapy for stage IB and II non-seminomatous testicular cancer.
- Journal / Conference
- Am J Clin Oncol (CCT) 6(2): 215-218
- Year
- 1983
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7624
Adriamycin versus adriamycin plus cis-diamminedichloro- platinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group study.
- Journal / Conference
- Cancer Treat Rep 67:1139-1140
- Year
- 1983
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7959
Mitoguazone in advanced renal carcinoma. A Phase II trial of the Southwest Oncology Group.
- Journal / Conference
- Cancer Treat Rep 67:1133-1135
- Year
- 1983
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8010